Empowering People Hurt by Big Businesses

Local (415) 857-7400
Toll Free (800) 824-8234

Blog Posts in June, 2014

  • FDA Requires Manufacturers To Put A General Warning About Venous Blood Clots Risks With Testosterone Products

    On 6/19/2014, the FDA issued a drug safety statement affecting all FDA-approved testosterone products currently on the market. According to the statement: "[FDA] is requiring manufacturers to include a general warning in the drug labeling of all approved testosterone products about the risk of blood clots in the veins. Blood clots in the veins, also known as venous thromboembolism (VTE), include ...
    Continue Reading
  • Weight Loss Drug Could Cause Cancer And Cardiac Problems

    The FDA recently cautioned consumers not to purchase or use La Jiao Shou Shen, a product promoted as a weight loss supplement. A laboratory analysis conducted by the FDA confirmed the product contains the undeclared ingredients sibutramine and phenolphthalein. Sibutramine is a controlled substance that was removed from the market in 2010 due to safety concerns. Sibutramine can "interact, in ...
    Continue Reading
Page 1 of 1